A study published last week provides further evidence directly linking bisphosphonates to an increased risk of jaw bone decay, known as osteonecrosis of the jaw. The study involved intravenous bisphosphonates which are used to treat bone cancer, osteoporosis and other conditions. Although the study did not address the… Read More
Yesterday the FDA issued a public health advisory regarding a risk of death associated with the use of Coly-Mycin M and generic forms of colistimethate when used in a premixed form for inhalation with a nebulizer. Although colistimethate is only approved by the FDA for intravenous… Read More
Yesterday Advanced Medical Optics, Inc. (AMO) revised their financial guidance to reflect the impact of the Complete MoisturePlus recall. The popular contact lens solution was removed from the market after CDC officials linked it to an increased risk of Acanthamoeba Keratitis, a rare and possibly blinding eye… Read More
Yesterday at the annual meeting of the American Diabetes Association in Chicago, the debate about heart risks associated with Avandia was a main topic. Concerns have been widespread among diabetes patients and doctors about an increased risk of heart attacks and heart related death since a… Read More
A Canadian law firm has filed a Fosamax class action lawsuit against Merck Frosst Canada, the manufacturer of the popular osteoporosis drug in Canada. The suit was filed because the drug maker failed to adequately warn patients and doctors about the risks of developing decay of… Read More
At Saiontz & Kirk, P.A., our lawyers are reviewing potential lawsuits for individuals who have been diagnosed with Nephrogenic Systemic Fibrosis, which has been directly linked to gadolinium-based contrast dyes used during MRI and MRA scans. Many people have contacted our office expressing concerns about the… Read More
Since last fall, there have been concerns about problems with drug eluting heart stents, which could increase the risk of potentially fatal blood clots. Researchers are developing a new type of absorbable heart stent, which could provide a safer alternative to replace drug eluting stents as… Read More
Since our law firm began representing individuals who developed Nephrogenic Systemic Fibrosis after receiving an MRI or MRA with contrast, we have spoken with many concerned individuals with serious skin problems who have not been diagnosed with the rare condition. Even without a diagnosis, our lawyers… Read More
Following a Zelnorm recall in the United States on March 30 2007, Swiss pharmaceutical regulators announced last week that they have ordered the manufacturer, Novartis AG, to remove the foreign equivalent, Zelmac, from the market. Swissmedic, the country’s regulatory agency, determined that the risk of heart… Read More
Yesterday the FDA issued letters to healthcare providers and contact lens wearers notifying them that the Complete MoisturePlus contact lens solution manufactured by Advanced Medical Optics, could cause Acanthamoeba Keratitis. The serious eye infection is painful and may result in permanent vision loss. >>INFORMATION: Acanthamoeba keratitis… Read More
